A review of vaccine research and development: human enteric infections - PubMed

Affiliations

• PMID: 16483695
• DOI: 10.1016/j.vaccine.2005.10.014

Review

A review of vaccine research and development: human enteric infections

Marc P Girard et al. Vaccine. 2006.

Abstract

Worldwide, enteric infections rank third among all causes of disease burden, being responsible for some 1.7-2.5 million deaths per year, mostly in young children and infants in developing countries. The main infectious agents responsible for human enteric infections include several viruses (enteric adenoviruses, astroviruses, human caliciviruses (HuCV), rotaviruses (RV)) and several bacterial agents, such as Campylobacter jejuni, a variety of pathogenic Escherichia coli strains including enterotoxigenic E. coli (ETEC), several Shigella species, various Salmonella strains including S. typhi and S. paratyphi, the agents of typhoid fever, and Vibrio cholerae, the agent of cholera. While effective vaccines are available at present against typhoid fever and cholera, no vaccine is available against illnesses caused by HuCV, Campylobacter, ETEC or the Shigellae. Rotavirus vaccines have had more success, although RV disease prevention suffered a major setback in 1999 with the withdrawal of a live simian-human reassortant RV vaccine less than a year after its introduction. New live oral RV vaccines have now been developed and are or should presently be ready for licensure. This article reviews the state of the art in vaccine R&D against human viral and bacterial enteric infections of public health importance.

Similar articles

• A review of the current status of enteric vaccines.

  Levine MM, Noriega F. Levine MM, et al. P N G Med J. 1995 Dec;38(4):325-31. P N G Med J. 1995. PMID: 9522876 Review.

• Bacterial enteric infections and vaccine development.

  Holmgren J, Svennerholm AM. Holmgren J, et al. Gastroenterol Clin North Am. 1992 Jun;21(2):283-302. Gastroenterol Clin North Am. 1992. PMID: 1512046 Review.

• Future vaccines against enteric pathogens.

  Levine MM, Edelman R. Levine MM, et al. Infect Dis Clin North Am. 1990 Mar;4(1):105-21. Infect Dis Clin North Am. 1990. PMID: 2155260 Review.

• The current status of diarrhoea related vaccines.

  Sarkar SK, Pal SC. Sarkar SK, et al. Indian J Public Health. 1990 Jan-Mar;34(1):20-34. Indian J Public Health. 1990. PMID: 1966245 Review.

• New vaccines against bacterial enteric infections.

  Holmgren J, Svennerholm AM. Holmgren J, et al. Scand J Infect Dis Suppl. 1990;70:149-56. Scand J Infect Dis Suppl. 1990. PMID: 2287897 Review.

Cited by

• Production of human rotavirus and Salmonella antigens in plants and elicitation of fljB-specific humoral responses in mice.

  Bergeron-Sandoval LP, Girard A, Ouellet F, Archambault D, Sarhan F. Bergeron-Sandoval LP, et al. Mol Biotechnol. 2011 Feb;47(2):157-68. doi: 10.1007/s12033-010-9324-z. Mol Biotechnol. 2011. PMID: 20725806

• Effectiveness and economic analysis of the whole cell/recombinant B subunit (WC/rbs) inactivated oral cholera vaccine in the prevention of traveller's diarrhoea.

  López-Gigosos R, Garcia-Fortea P, Calvo MJ, Reina E, Diez-Diaz R, Plaza E. López-Gigosos R, et al. BMC Infect Dis. 2009 May 16;9:65. doi: 10.1186/1471-2334-9-65. BMC Infect Dis. 2009. PMID: 19445712 Free PMC article.

• Mucosal vaccines: wisdom from now and then.

  Kiyono H, Yuki Y, Nakahashi-Ouchida R, Fujihashi K. Kiyono H, et al. Int Immunol. 2021 Nov 25;33(12):767-774. doi: 10.1093/intimm/dxab056. Int Immunol. 2021. PMID: 34436595 Free PMC article. Review.

• Modified heat-stable toxins (hSTa) of enterotoxigenic Escherichia coli lose toxicity but display antigenicity after being genetically fused to heat-labile toxoid LT(R192G).

  Liu M, Zhang C, Mateo K, Nataro JP, Robertson DC, Zhang W. Liu M, et al. Toxins (Basel). 2011 Sep;3(9):1146-62. doi: 10.3390/toxins3091146. Epub 2011 Sep 15. Toxins (Basel). 2011. PMID: 22069760 Free PMC article.

• Critical analysis of compositions and protective efficacies of oral killed cholera vaccines.

  Kabir S. Kabir S. Clin Vaccine Immunol. 2014 Sep;21(9):1195-205. doi: 10.1128/CVI.00378-14. Epub 2014 Jul 23. Clin Vaccine Immunol. 2014. PMID: 25056361 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information